NEW YORK – German startup Osteolabs announced on Monday its first commercialization agreements covering Germany and Turkey.
In Germany, Osteolabs has signed a deal with Eurofins LifeCodexx to commercialize Osteolabs' diagnostic test for the early detection of osteoporosis. The company has reached a similar deal in Turkey with BioGen Medical.